Anti-atherosclerotic agents of the formula: ##STR1## wherein R.sup.1 is (a) alkyl having from 1 to 22 carbon atoms; or (b) of the formula ##STR2## in which m is 0, 1 or 2, and each of R' and R" is, independently, hydrogen, halo or lower alkyl or alkoxy; R.sup.2 and R.sup.3 are joined to form with the silicon atom a heterocyclic ring having from 3 to 20 ring members; and R is an aralkyl-, phenyl- tryptophanyl- or benzocycloalkyl-type radical, eg 1-butyl-N-[(2-(4'-methyl-phenyl)-1-phenylethyl]-1-silacyclohexane propanamide, are obtained by reducing corresponding .alpha.,.beta.-unsaturated analogs.
公式为:##STR1## 其中R.sup.1是(a)碳原子数为1至22的烷基; 或(b)公式##STR2## 其中m为0、1或2,R'和R"各自独立地为氢、卤素或低烷基或烷氧基; R.sup.2和R.sup.3与
硅原子结合形成具有3至20个环成员的杂环环; R为芳基烷基、苯基色
氨酸基或苯并环烷基类型的基团,例如1-丁基-N-[(2-(4'-甲基苯基)-1-苯基乙基]-1-
硅杂
环己烷丙酰胺,可通过还原相应的α,β-不饱和类似物获得。